Double Blind Atorvastatin Amlodipine Study (DUAAL) Effect Of Amlodipine, Atorvastatin And The Combination On Transient Myocardia Ischemia In Coronary Artery Disease

Trial Profile

Double Blind Atorvastatin Amlodipine Study (DUAAL) Effect Of Amlodipine, Atorvastatin And The Combination On Transient Myocardia Ischemia In Coronary Artery Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Amlodipine; Atorvastatin
  • Indications Angina pectoris; Coronary artery disease; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms DUAAL
  • Sponsors Pfizer
  • Most Recent Events

    • 02 Apr 2008 Results were presented at the 57th Annual meeting of the American College of Cardiology.
    • 17 Feb 2007 Status change from in progress to completed.
    • 12 Jan 2007 Status changed from recruiting to in progress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top